NCT01034774View on ClinicalTrials.gov

Phase 1 Study to Determine Safety, Blood PK and Lung Penetration

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

July 31, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

ACHN-490 Injection

ACHN-490 Injection at 15mg/kg is given either 1 or 5 consecutive days. Cohort 1 receives 5 consecutive days of treatment and Cohort 2 receives a single dose of treatment.

DRUG

Placebo (normal saline)

Placebo is given at the same volume as ACHN-490 Injection to maintain the blind.

Sponsors

Lead Sponsor

Achaogen, Inc.
All Listed Sponsors
lead

Achaogen, Inc.

INDUSTRY